Log In
BCIQ
Print this Print this
 

TGBA01AD

  Manage Alerts
Collapse Summary General Information
Company Fabre-Kramer Pharmaceuticals Inc.
DescriptionAntidepressant agonist of serotonin (5-HT2) receptor and serotonin (5-HT1A) receptor
Molecular Target Serotonin (5-HT1A) receptor ; Serotonin (5-HT2) receptor
Mechanism of ActionSerotonin (5-HT1A) receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationDepression
Indication DetailsTreat depression
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today